Professor Marcelin: Currently we have the reserves of the phase II studies for some protease inhibitor especially for two protease inhibitors telaprevir and boceprevir.
Marcelin教授：目前，对某些蛋白酶抑制剂，我们已经积累了大量的二期临床研究成果，尤其是Telaprevir和Boceprevir这两种蛋白酶抑制剂。
Professor Marcelin: Currently we have the reserves of the phase II studies for some protease inhibitor especially for two protease inhibitors telaprevir and boceprevir.
Marcelin教授：目前，对某些蛋白酶抑制剂，我们已经积累了大量的二期临床研究成果，尤其是Telaprevir和Boceprevir这两种蛋白酶抑制剂。
应用推荐